Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway-Reference-Cited by-全球学者库

Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway

Published:2018-02-07 Issue:4 Volume:67 Page:1303-1319
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lu Yao¹²,Jiang Zhou³,Dai Haijiang¹,Miao Rujia⁴,Shu Jingxian¹,Gu Haotian²,Liu Xing¹,Huang Zhijun¹,Yang Guoping¹,Chen Alex F.¹,Yuan Hong¹,Li Ying⁴,Cai Jingjing⁵

Affiliation:

1. Center of Clinical Pharmacology, Third Xiangya Hospital; Central South University; Changsha China

2. Department of Clinical Pharmacology; St. Thomas' Hospital, KCL; London UK

3. Institute of Model Animal of Wuhan University; Wuhan China

4. Health Management Center, Third Xiangya Hospital; Central South University; Changsha China

5. Department of Cardiology, Third Xiangya Hospital; Central South University; Changsha China

Funder

National Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

1. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD);Stepanova;Dig Dis Sci,2013

2. Insulin resistance, inflammation, and non-alcoholic fatty liver disease;Tilg;Trends Endocrinol Metab,2008

3. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes;Birkenfeld;Hepatology,2014

4. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis;Dixon;Nature,1990

5. Macrophages, inflammation, and insulin resistance;Olefsky;Annu Rev Physiol,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets;Biomolecules;2024-02-04

2. Immunoglobulin-like receptors in chickens: identification, functional characterization, and renaming to cluster homolog of immunoglobulin-like receptors;Poultry Science;2024-02

3. Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors;Cell Reports Medicine;2024-01

4. Research progress of B subfamily of leucocyte immunoglobulin‐like receptors in inflammation;International Journal of Immunogenetics;2023-04-11

5. Molecular and Pathological Analyses of IARS1-Deficient Mice: An IARS Disorder Model;International Journal of Molecular Sciences;2023-04-09